Yumanity Therapeutics (FRA:8IY) Pre-Tax Income : €-29.34 Mil (TTM As of Sep. 2022)

Yumanity Therapeutics Pre-Tax Income Chart

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Pre-Tax Income	Get a 7-Day Free Trial							-8.46	-9.21	-12.15	-4.58	-3.40

Competitive Comparison of Yumanity Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Yumanity Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yumanity Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yumanity Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Yumanity Therapeutics's Pre-Tax Income falls into.

Yumanity Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Yumanity Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2021 is calculated as

Yumanity Therapeutics's Pretax Income for the quarter that ended in Sep. 2022 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-29.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yumanity Therapeutics  (FRA:8IY) Pre-Tax Income Explanation

Yumanity Therapeutics's Pretax Margin for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yumanity Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description